Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT01585922 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Noninvasive Positive Pressure Ventilation in Moderate Acute Respiratory Distress Syndrome

Start date: July 2012
Phase: N/A
Study type: Interventional

In order to identify the effect of noninvasive positive pressure ventilation (NPPV) on decreasing inflammatory response, improving the pathophysiological manifestation and reducing the morbidity and mortality in the moderate acute respiratory distress syndrome (ARDS) patients, the investigators conduct this clinical trial comparing NPPV with invasive mechanical ventilation in more than twenty ICUs in China.

NCT ID: NCT01585831 Completed - Clinical trials for Klinefelter Syndrome

Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome

TestoXXY/KS
Start date: March 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if testosterone replacement therapy leads to changes in psychological factors and/or motor skills in adolescent males with 47,XXY (also called Klinefelter syndrome). This study will also evaluate whether certain genetic factors of the X chromosome affect the psychological or motor features of XXY/Klinefelter syndrome.

NCT ID: NCT01584934 Withdrawn - Clinical trials for Chronic Fatigue Syndrome

Sodium Oxybate in Patients With Chronic Fatigue Syndrome.

Start date: June 2013
Phase: Phase 4
Study type: Interventional

Chronic fatigue syndrome (CFS) is a disabling, unexplained disorder characterized by physical and mental exhaustion. Complaints of disturbed and unrefreshing sleep are very common in CFS patients, however, the relationship between (disturbed) sleep quality and fatigue is still not fully elucidated. To evaluate the effect of sodium oxybate on fatigue and to explore the interdependence of sleep quality and fatigue in CFS, a double blind, randomized, placebo controlled cross-over trial with sodium oxybate is carried out in CFS patients. The aim of this study is to address the issue of the effect of sodium oxybate on fatigue as a presenting symptom in chronic fatigue (CF) and CFS patients, in the absence of underlying medical or psychiatric illness. The answer to this question may shed further light on the enigmatic relationship between sleep and fatigue. We also want to investigate the effect of sodium oxybate on sleepiness and general health in the same target population. Zero-hypothesis: there is no effect.

NCT ID: NCT01584531 Completed - Clinical trials for Myelodysplastic Syndrome

Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome

ONTARGET
Start date: May 2012
Phase: Phase 2
Study type: Interventional

The primary objectives of this study are to determine if rigosertib sodium, given orally in the form of soft gel capsules, is safe and is associated with a reduction in the number of blood transfusion units that are needed in patients with myelodysplastic syndrome (MDS) classified as Low or Intermediate-1 (Int-1) (any cytogenetics) or trisomy 8 Intermediate 2 (Int-2) in the International Prognostic Scoring System (IPSS) who are transfusion-dependent. Rigosertib will be taken on days 1 to 21 of a 21-day cycle.

NCT ID: NCT01584427 Completed - Metabolic Syndrome Clinical Trials

ButCoIns - Metabolic Effects of Resistent Starch and Arabinoxylans in Subjects With Metabolic Syndrome

ButCoIns
Start date: April 2012
Phase: N/A
Study type: Interventional

Background Life style related disease is an increasing problem all over the world. The Metabolic Syndrome (MetS) is a condition characterized by abdominal obesity, high blood lipids, high blood pressure and slightly elevated blood sugar. Subjects with MetS have high risk of developing Type 2 Diabetes and cardiovascular disease. Dietary fibers have been shown to have positive effects on the components of MetS. The investigators have special interest in the combination of two types of fiber (Resistant (RS) starch and Arabinoxylans (AX)) . Hypotheses Increase of RS and AX in the dietary composition has a positive effects on components of MetS i.e. decreases blood lipids, improves blood sugar, blood pressure and markers of inflammation. The subjects undergo two dietary interventions of 4 weeks duration each: A "Healthy Carbohydrate Diet" with a high content of RS and AX is compared to a "Western Style Diet" with a low content of RS and AX.

NCT ID: NCT01582841 Completed - Colon Cancer Clinical Trials

Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting

HNPCC
Start date: February 2012
Phase: N/A
Study type: Interventional

The investigators research mobilizes the resources of an integrated health-delivery system with extensive electronic clinical data to implement and evaluate a new strategy to maximize screening of Colorectal Cancer (CRC) patients for Lynch Syndrome.

NCT ID: NCT01582763 Active, not recruiting - Clinical trials for Guillain-Barré Syndrome

International Guillain-Barré Syndrome Outcome Study

IGOS
Start date: May 1, 2012
Phase:
Study type: Observational

International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barré syndrome (GBS). The IGOS aims to identify clinical and biological determinants and predictors of disease course and outcome in individual patients with Guillain-Barré syndrome, as early as possible after onset of disease.

NCT ID: NCT01582529 Completed - Clinical trials for Hypoplastic Left Heart Syndrome

SVRII Family Factors Study

Start date: June 2012
Phase:
Study type: Observational

The purpose of this study is to learn about the relationship between family factors and developmental and psychosocial outcomes in children with congenital heart disease at 6 years of age. A secondary purpose is to learn more about psychosocial outcomes in children with congenital heart disease and their families over time. About 250 mothers and fathers at 15 medical centers will take part in this study; 35 will be from Children's Hospital of Wisconsin.

NCT ID: NCT01579396 Withdrawn - Acute Kidney Injury Clinical Trials

High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After Cardiac Surgery

HICOSIRS
Start date: April 2012
Phase: N/A
Study type: Interventional

A high cut off dialyzer (septeX) is tested in patients after cardio-thoracic surgery with incidence of "systemic inflammatory response syndrome" (SIRS) and associated increased risk for acute kidney injury (AKI). Hypothesis: The high cut off dialyzer (septeX) can increase the postoperative IL-6/Il-10 ratio.

NCT ID: NCT01578122 Completed - Clinical trials for Deep Vein Thrombosis

Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome

CELEST
Start date: June 29, 2012
Phase: N/A
Study type: Interventional

Post thrombotic syndrome (PTS) is a frequent and burdensome complication of proximal deep-vein thrombosis.Therapeutic options for PTS are limited and mainly rely on its prevention. Therapeutic trials evidenced that elastic compression stockings (ECS) applying 30-40mmHg of pressure at the ankle reduced the rate of PTS by 50%. Although ECS are unlikely to cause harm, in clinical practice, compliance to this treatment appears to be low as ECS may be difficult to apply and to wear. ECS with a lighter compression strength (20-30mmHg) might be easier to apply and be more comfortable. This could favor a better compliance. CELEST is a randomized, multicentre, double-blind trial which aims to determine whether ECS applying 25mmHg of targeted pressure at the ankle are non inferior to ECS applying 35mmHg of targeted pressure at the ankle